Christian M. Jespersen

Author

Also Known As

&NA;, C Jespersen, C M Jespersen, C. M Jespersen, C. M. JESPERSEN, C. M. Jespersen, CHRISTIAN M. JESPERSEN, Christian M Jespersen, Christian M. Jespersen, H-H Chao

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Hvidovre Hospital Frederiksberg Hospital Odense University Hospital Rigshospitalet Bispebjerg Hospital

About

Christian M. Jespersen is an author at Hvidovre Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	370
2	Emergency Medicine	5	5	114
3	Public Health	3	3	61
4	Cardiothoracic Surgery	2	2	107
5	Endocrinology	1	1	39

Christian M. Jespersen

Publications

941

Citations

H-Index

Page 1

	Year	Citations
High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease Jens Kastrup, Julia S. Johansen, Per Winkel, European Heart Journal	2009	159
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial Christian M. Jespersen, Bodil Als‐Nielsen, Morten Damgaard, BMJ	2005	153
Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: A randomized, placebo-controlled, multicenter clinical trial Keyvan Karkouti, Christian von Heymann, Christian M. Jespersen, Journal of Thoracic and Cardiovascular Surgery Cardiac SurgeryRecombinant Factor XiiiCardiovascular DiseaseTransfusion MedicineBlood Transfusions	2013	85
Clarithromycin for 2 Weeks for Stable Coronary Heart Disease: 6-Year Follow-Up of the CLARICOR Randomized Trial and Updated Meta-Analysis of Antibiotics for Coronary Heart Disease Christian Gluud, Bodil Als‐Nielsen, Morten Damgaard, Cardiology	2008	59
Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer Ravi Gill, Nancy A. Nussmeier, Peter Skov Olsen, Thrombosis and Haemostasis	2009	46
Effects of Natural Oestrogen Therapy on Blood Pressure and Renin-angiotensin System in Normotensive and Hypertensive Menopausal Women Christian M. Jespersen, Klaus Arnung, Claus Hagen, Journal of Hypertension HypertensionUrologyCardiovascular DiseaseAntihypertensive TherapyHypertensive Menopausal Women	1983	39
Circadian variation in the pharmacokinetics of verapamil Christian M. Jespersen, M. Frederiksen, J. F. Hansen, European Journal of Clinical Pharmacology SleepChronobiologyAlertnessCircadian VariationMedicine	1989	39
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial Erik Kjøller, Jørgen Hilden, Per Winkel, American Heart Journal Health PolicyCardiovascular DiseaseCoronary Artery DiseaseClinical TrialsRandomized Controlled Trial	2014	35
High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial Marina Harutyunyan, Anders Bruun Mathiasen, Per Winkel, Scandinavian Journal of Clinical and Laboratory Investigation	2010	33
Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction J. F. Hansen, Lisbeth Tingsted, Verner Rasmussen, The American Journal of Cardiology Angiotensin-converting Enzyme InhibitorsHypertensionHeart FailureCardiovascular DiseaseMedicine	1996	32

Page 1